{
  "cik": 1674416,
  "cik_padded": "0001674416",
  "entityName": "CRISPR Therapeutics AG",
  "fiscal_years": [
    {
      "accn": "0001193125-26-048957",
      "filed": "2026-02-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 914000.0,
        "cash": 347559000.0,
        "eps_diluted": -6.47,
        "free_cash_flow": -345928000.0,
        "net_income": -581599000.0,
        "operating_cash_flow": -345014000.0,
        "operating_income": -664571000.0,
        "revenue": 3510000.0,
        "stockholders_equity": 1921813000.0,
        "total_assets": 2265243000.0,
        "total_liabilities": 343430000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.17870104947775875,
        "revenue_growth_yoy": -0.9059334298118669,
        "roa_avg2y": -0.2580711147772813,
        "roa_period_end": -0.2567490551786276,
        "roe_avg2y": -0.3018241554708447,
        "roe_period_end": -0.30263038079147137
      }
    },
    {
      "accn": "0001193125-26-048957",
      "filed": "2026-02-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1901000.0,
        "cash": 298257000.0,
        "eps_diluted": -4.34,
        "free_cash_flow": -144675000.0,
        "net_income": -366252000.0,
        "operating_cash_flow": -142774000.0,
        "operating_income": -466566000.0,
        "revenue": 37314000.0,
        "stockholders_equity": 1932080000.0,
        "total_assets": 2242034000.0,
        "total_liabilities": 309954000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1604250341600762,
        "revenue_growth_yoy": -0.8994789954903746,
        "roa_avg2y": -0.16381232242114407,
        "roa_period_end": -0.16335702313167422,
        "roe_avg2y": -0.1920121796657984,
        "roe_period_end": -0.1895635791478614
      }
    },
    {
      "accn": "0001193125-26-048957",
      "filed": "2026-02-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9470000.0,
        "cash": 389477000.0,
        "eps_diluted": -1.94,
        "free_cash_flow": -269845000.0,
        "net_income": -153610000.0,
        "operating_cash_flow": -260375000.0,
        "operating_income": -222538000.0,
        "revenue": 371206000.0,
        "stockholders_equity": 1882803000.0,
        "total_assets": 2229571000.0,
        "total_liabilities": 346768000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.18417646455842698,
        "net_margin": -0.41381335431000577,
        "operating_margin": -0.599500008081766,
        "revenue_growth_yoy": 308.85475792988314,
        "roa_avg2y": -0.06868892293300494,
        "roa_period_end": -0.06889666218299395,
        "roe_avg2y": -0.08174479722383791,
        "roe_period_end": -0.08158580584373405
      }
    },
    {
      "accn": "0001193125-26-048957",
      "filed": "2026-02-12",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 37188000.0,
        "cash": 211885000.0,
        "eps_diluted": -8.36,
        "free_cash_flow": -532929000.0,
        "net_income": -650175000.0,
        "operating_cash_flow": -495741000.0,
        "operating_income": -673161000.0,
        "revenue": 1198000.0,
        "stockholders_equity": 1875479000.0,
        "total_assets": 2243057000.0,
        "total_liabilities": 367578000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.19599153069695796,
        "revenue_growth_yoy": -0.9986906574364209,
        "roa_avg2y": -0.2603337701759423,
        "roa_period_end": -0.28986111364980915,
        "roe_avg2y": -0.30417977893953574,
        "roe_period_end": -0.34667143700356023
      }
    },
    {
      "accn": "0000950170-25-017899",
      "filed": "2025-02-11",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 81705000.0,
        "cash": 923031000.0,
        "eps_diluted": 4.7,
        "free_cash_flow": 457267000.0,
        "net_income": 377661000.0,
        "operating_cash_flow": 538972000.0,
        "operating_income": 373528000.0,
        "revenue": 914963000.0,
        "stockholders_equity": 2399460000.0,
        "total_assets": 2751877000.0,
        "total_liabilities": 352417000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14687346319588573,
        "net_margin": 0.4127609531751557,
        "operating_margin": 0.40824383062484493,
        "revenue_growth_yoy": 1271.549374130737,
        "roa_avg2y": 0.16492312072706422,
        "roa_period_end": 0.1372376018259537,
        "roe_avg2y": 0.18587078653067873,
        "roe_period_end": 0.15739416368682954
      }
    },
    {
      "accn": "0000950170-24-017571",
      "filed": "2024-02-21",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 18358000.0,
        "cash": 1168620000.0,
        "eps_diluted": -5.29,
        "free_cash_flow": -256724000.0,
        "net_income": -348865000.0,
        "operating_cash_flow": -238366000.0,
        "operating_income": -354435000.0,
        "revenue": 719000.0,
        "stockholders_equity": 1664234000.0,
        "total_assets": 1827966000.0,
        "total_liabilities": 163732000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09838279953420012,
        "revenue_growth_yoy": -0.9975171794606167,
        "roa_avg2y": -0.24103556892243044,
        "roa_period_end": -0.19084873569858518,
        "roe_avg2y": -0.26798056120252306,
        "roe_period_end": -0.20962496860417462
      }
    },
    {
      "accn": "0001564590-21-006074",
      "filed": "2023-02-21",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6684000.0,
        "cash": 943771000.0,
        "eps_diluted": 1.17,
        "free_cash_flow": 49993000.0,
        "net_income": 66858000.0,
        "operating_cash_flow": 56677000.0,
        "operating_income": 46740000.0,
        "revenue": 289590000.0,
        "stockholders_equity": 939425000.0,
        "total_assets": 1066752000.0,
        "total_liabilities": 127327000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1355371636905554,
        "net_margin": 0.23087123174142754,
        "operating_margin": 0.16140060084947686,
        "revenue_growth_yoy": 91.69846350832266,
        "roa_avg2y": 0.08594854759835657,
        "roa_period_end": 0.06267436105111591,
        "roe_avg2y": 0.10041603460446674,
        "roe_period_end": 0.07116906618410197
      }
    },
    {
      "accn": "0001564590-21-006074",
      "filed": "2022-02-15",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2773000.0,
        "cash": 456649000.0,
        "eps_diluted": -3.44,
        "free_cash_flow": -99012000.0,
        "net_income": -164981000.0,
        "operating_cash_flow": -96239000.0,
        "operating_income": -158943000.0,
        "revenue": 3124000.0,
        "stockholders_equity": 392195000.0,
        "total_assets": 489016000.0,
        "total_liabilities": 96821000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.24686954193704663,
        "roa_avg2y": -0.43395382725596493,
        "roa_period_end": -0.33737341927462494,
        "roe_avg2y": -0.5688735179569226,
        "roe_period_end": -0.4206606407526868
      }
    },
    {
      "accn": "0001564590-21-006074",
      "filed": "2021-02-16",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7814000.0,
        "cash": 239758000.0,
        "eps_diluted": -1.71,
        "free_cash_flow": -77907000.0,
        "net_income": -68357000.0,
        "operating_cash_flow": -70093000.0,
        "operating_income": -64648000.0,
        "stockholders_equity": 187832000.0,
        "total_assets": 271346000.0,
        "total_liabilities": 83514000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4446207249031049,
        "roa_avg2y": -0.22182739798931703,
        "roa_period_end": -0.25191821512017865,
        "roe_avg2y": -0.324984905319508,
        "roe_period_end": -0.3639262745432088
      }
    },
    {
      "accn": "0001564590-20-004355",
      "filed": "2020-02-12",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3016000.0,
        "cash": 315520000.0,
        "free_cash_flow": -55876000.0,
        "net_income": -23177000.0,
        "operating_cash_flow": -52860000.0,
        "operating_income": -68130000.0,
        "stockholders_equity": 232846000.0,
        "total_assets": 344962000.0,
        "total_liabilities": 112116000.0
      },
      "period_end": "2016-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4815027958393101,
        "roa_period_end": -0.067187110464341,
        "roe_period_end": -0.09953789199728576
      }
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-048957",
    "filed": "2026-02-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001674416.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001674416.json"
  },
  "ticker": "CRSP"
}
